Back to search

Article

Bioengineering vaccinia virus envelope protein to purify size-specific anticoagulant oligosaccharides from heterogeneous heparins

2023-06-10

Abstract excerpt

<title>Abstract</title> <p>Ultra-low molecular weight heparins (ULMWHs) are being used as anticoagulant drugs that exhibit a low risk, long lifetime and high efficacy. However, a robust and cost-effective purification methodology to isolate ULMWHs from naturally occurring heparins (HPs) is lacking. Vaccinia virus envelope protein A27 and a truncated variant (sA27-aa) bind specifically to HPs for virus/cell attach...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f28e2f4f-12ed-5523-bb0b-c4959089edb9
DOI
10.21203/rs.3.rs-3031779/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Bioengineering vaccinia virus envelope protein to purify size-specific anticoagulant oligosaccharides from heterogeneous heparinsDOI 10.21203/rs.3.rs-3031779/v1
Select a neighboring publication to make it the new centre.